Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Remuzzi

Showing results (201-210 of 894) with videos related to

Pageof 90
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2024
Tissue-Resident Macrophages in Solid Organ Transplantation: Harmful or Protective?Sistiana Aiello, Ariela Benigni, Giuseppe Remuzzi
Pharmacological Reviews|May 18, 2025
Innovative therapeutics for renoprotection: Where we areMonica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 1, 2001
ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in NephropathyPiero Ruggenenti, Annalisa Perna, Giuseppe Remuzzi
Lancet (London, England)|September 21, 2002
Tacrolimus and ciclosporin microemulsion in renal transplantationArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|May 23, 2003
Proteinuria and phenotypic change of proximal tubular cellsCarla Zoja, Marina Morigi, Giuseppe Remuzzi
Diabetes|September 1, 2010
Comment on: Robertson (2010) Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes;59:1285-1291Paolo Cravedi, Andrea Remuzzi, Giuseppe Remuzzi
Seminars in Dialysis|July 4, 2009
Treatment of bleeding in dialysis patientsMiriam Galbusera, Giuseppe Remuzzi, Paola Boccardo
Nephron|April 27, 2020
Reply to the Comment by Dr. Cure on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade"Luca Perico, Ariela Benigni, Giuseppe Remuzzi
Nature Reviews. Drug Discovery|December 4, 2002
New therapeutics that antagonize endothelin: promises and frustrationsGiuseppe Remuzzi, Norberto Perico, Ariela Benigni
Current Hypertension Reports|September 2, 2003
Angiotensin-converting enzyme inhibition or angiotensin receptor blockade in hypertensive diabetics?Gozewÿn Laverman, Piero Ruggenenti, Giuseppe Remuzzi
Pageof 90

Showing results (201-210 of 894) with videos related to

Sort By:
Pageof 90
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2024
Tissue-Resident Macrophages in Solid Organ Transplantation: Harmful or Protective?Sistiana Aiello, Ariela Benigni, Giuseppe Remuzzi
Pharmacological Reviews|May 18, 2025
Innovative therapeutics for renoprotection: Where we areMonica Cortinovis, Norberto Perico, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|December 1, 2001
ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in NephropathyPiero Ruggenenti, Annalisa Perna, Giuseppe Remuzzi
Lancet (London, England)|September 21, 2002
Tacrolimus and ciclosporin microemulsion in renal transplantationArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Journal of the American Society of Nephrology : JASN|May 23, 2003
Proteinuria and phenotypic change of proximal tubular cellsCarla Zoja, Marina Morigi, Giuseppe Remuzzi
Diabetes|September 1, 2010
Comment on: Robertson (2010) Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes;59:1285-1291Paolo Cravedi, Andrea Remuzzi, Giuseppe Remuzzi
Seminars in Dialysis|July 4, 2009
Treatment of bleeding in dialysis patientsMiriam Galbusera, Giuseppe Remuzzi, Paola Boccardo
Nephron|April 27, 2020
Reply to the Comment by Dr. Cure on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade"Luca Perico, Ariela Benigni, Giuseppe Remuzzi
Nature Reviews. Drug Discovery|December 4, 2002
New therapeutics that antagonize endothelin: promises and frustrationsGiuseppe Remuzzi, Norberto Perico, Ariela Benigni
Current Hypertension Reports|September 2, 2003
Angiotensin-converting enzyme inhibition or angiotensin receptor blockade in hypertensive diabetics?Gozewÿn Laverman, Piero Ruggenenti, Giuseppe Remuzzi
Pageof 90